Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Net Income towards Common Stockholders (2019 - 2021)

Inventiva (IVEVF) posted Net Income towards Common Stockholders of -$11.9 million for Q2 2021, down 167.99% on a QoQ basis from -$4.4 million in Q1 2021, and down 22.57% year-over-year from -$15.4 million in Q2 2020.

Analysis

Inventiva (IVEVF) Net Income towards Common Stockholders (2019 - 2021) Analysis & Trends

Inventiva has reported Net Income towards Common Stockholders for 3 years, with the latest figure at -$11.9 million in Q2 2021.

  • On a quarterly basis, Net Income towards Common Stockholders fell 22.57% year-over-year to -$11.9 million in Q2 2021; TTM through Jun 2021 was -$66.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $93.2 million, up 1703.95% from the prior year.
  • Net Income towards Common Stockholders was -$11.9 million for Q2 2021 at Inventiva, down from -$4.4 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was -$4.4 million in Q1 2021, with the low at -$40.1 million in Q4 2020.
  • Average Net Income towards Common Stockholders over 3 years is -$17.8 million, with a median of -$10.8 million recorded in 2020.
  • The largest YoY upside for Net Income towards Common Stockholders was 40.67% in 2021 against a maximum downside of 22.57% in 2021.
  • Over 3 years, Net Income towards Common Stockholders stood at -$33.4 million in 2019, then slipped by 20.07% to -$40.1 million in 2020, then jumped by 70.36% to -$11.9 million in 2021.
  • The last three Net Income towards Common Stockholders figures came in at -$11.9 million (Q2 2021), -$4.4 million (Q1 2021), and -$40.1 million (Q4 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Johnson & Johnson 645.95 Bn 625.20 Bn 17.26 Bn 5.53 Bn
2 AbbVie 441.39 Bn 434.82 Bn 12.70 Bn 3.62 Bn
3 Merck 366.72 Bn 359.58 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 266.68 Bn 258.99 Bn 11.24 Bn 3.26 Bn
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn -238.00 Mn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 398.69 Mn
7 Revolution Medicines 44.08 Bn 44.08 Bn - -644.37 Mn
8 Incyte 25.50 Bn 20.96 Bn 1.57 Bn 585.61 Mn
9 United Therapeutics 21.54 Bn 18.88 Bn 683.80 Mn 333.00 Mn
10 Inventiva 693.72 Mn 693.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -11.89 Mn
Mar 31, 2021 -4.44 Mn
Dec 31, 2020 -40.11 Mn
Jun 30, 2020 -9.70 Mn
Mar 31, 2020 -7.48 Mn
Dec 31, 2019 -33.40 Mn